Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 639321, 8 pages
http://dx.doi.org/10.1155/2014/639321
Research Article

Sequence Variation in the E2-Binding Domain of HPV16 and Biological Function Evaluation in Tunisian Cervical Cancers

1Unit of Immuno-Microbio-Environmental and Carcinogenesis (IMEC), Faculty of Sciences, University of Carthage, Jarzouna, 7021 Bizerta, Tunisia
2Radio-oncology Department, Salah Azaiz Institute, 1006 Tunis, Tunisia
3Research Laboratory of Antimicrobial Resistance, Faculty of Medicine of Tunis, 1007 Tunis, Tunisia
4Service of Gynaecology Obstetrics A, Center of Maternity and Neonatology, Hospital La Rabta, 1007 Tunis, Tunisia

Received 19 February 2014; Revised 22 May 2014; Accepted 30 May 2014; Published 17 June 2014

Academic Editor: Anton M. Jetten

Copyright © 2014 Saloua Kahla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Castellsagué, F. X. Bosch, and N. Muñoz, “Environmental co-factors in HPV carcinogenesis,” Virus Research, vol. 89, no. 2, pp. 191–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Muñoz, F. X. Bosch, S. De Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Tornesello, L. Buonaguro, P. Giorgi-Rossi, and F. M. Buonaguro, “Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer,” Biomed Research International, vol. 2013, Article ID 519619, 10 pages, 2013. View at Publisher · View at Google Scholar
  4. R. Zappacosta, A. Colasante, P. Viola et al., “Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications,” Biomed Research International, vol. 2013, Article ID 453606, 11 pages, 2013. View at Publisher · View at Google Scholar
  5. M. Pett and N. Coleman, “Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?” Journal of Pathology, vol. 212, no. 4, pp. 356–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Longworth and L. A. Laimins, “Pathogenesis of human papillomaviruses in differentiating epithelia,” Microbiology and Molecular Biology Reviews, vol. 68, no. 2, pp. 362–372, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Sashiyama, Y. Shino, Y. Kawamata et al., “Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16,” International Journal of Oncology, vol. 19, no. 1, pp. 97–103, 2001. View at Google Scholar · View at Scopus
  8. A. Nishimura, T. Ono, A. Ishimoto et al., “Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition,” Journal of Virology, vol. 74, no. 8, pp. 3752–3760, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. McBride, “Chapter 4 replication and partitioning of papillomavirus genomes,” Advances in Virus Research, vol. 72, pp. 155–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Antson, J. E. Burns, O. V. Moroz et al., “Structure of the intact transactivation domain of the human papillomavirus E2 protein,” Nature, vol. 403, no. 6771, pp. 805–809, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Y. Hou, S.-Y. Wu, and C.-M. Chiang, “Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding,” Journal of Biological Chemistry, vol. 277, no. 47, pp. 45619–45629, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Thierry, “Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma,” Virology, vol. 384, no. 2, pp. 375–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-H. Tan, L. E.-C. Leong, P. A. Walker, and H.-U. Bernard, “The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID,” Journal of Virology, vol. 68, no. 10, pp. 6411–6420, 1994. View at Google Scholar · View at Scopus
  14. H. Arias-Pulido, C. L. Peyton, N. E. Joste, H. Vargas, and C. M. Wheeler, “Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer,” Journal of Clinical Microbiology, vol. 44, no. 5, pp. 1755–1762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Gray, M. R. Pett, D. Ward et al., “In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis,” Cancer Research, vol. 70, no. 10, pp. 4081–4091, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Gao, M.-M. Pan, Y.-J. Lei et al., “A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter,” BMC Molecular Biology, vol. 13, article 5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Giannoudis, M. Van Duin, P. J. F. Snijders, and C. S. Herrington, “Variation in the E2-binding domain of PHV 16 is associated with high-grade squamous intraepithelial lesions of the cervix,” British Journal of Cancer, vol. 84, no. 8, pp. 1058–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Graham and C. S. Herrington, “HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities,” Journal of Clinical Pathology: Molecular Pathology, vol. 53, no. 4, pp. 201–206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Veress, K. Szarka, X.-P. Dong, L. Gergely, and H. Pfister, “Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16,” Journal of General Virology, vol. 80, no. 4, pp. 1035–1043, 1999. View at Google Scholar · View at Scopus
  20. Y.-Y. Yang, L.-W. Koh, J.-H. Tsai et al., “Correlation of viral factors with cervical cancer in Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 37, no. 5, pp. 282–287, 2004. View at Google Scholar · View at Scopus
  21. B. Bhattacharjee and S. Sengupta, “HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women,” Gynecologic Oncology, vol. 100, no. 2, pp. 372–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Sima, S. Wang, W. Wang et al., “Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells,” Gynecologic Oncology, vol. 106, no. 2, pp. 299–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ferenczy and E. Franco, “Cervical-cancer screening beyond the year 2000,” The Lancet Oncology, vol. 2, no. 1, pp. 27–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Jiang, J. G. Baseman, L. A. Koutsky et al., “Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR,” Journal of Clinical Microbiology, vol. 47, no. 3, pp. 521–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Xue, D. Lim, L. Zhi, P. He, J. P. Abastado, and F. Thierry, “Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression,” The Open Virology Journal, vol. 6, pp. 163–172, 2012. View at Publisher · View at Google Scholar
  26. S. Kahla, L. Kochbati, M. B. Chanoufi, M. Maalej, and R. Oueslati, “HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas,” The International Journal of Biological Markers, vol. 29, no. 1, pp. 78–85, 2014. View at Publisher · View at Google Scholar
  27. R. E. Zuna, E. Tuller, N. Wentzensen et al., “HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer,” Infectious Agents and Cancer, vol. 6, no. 1, article 19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-U. Bernard, R. D. Burk, Z. Chen, K. van Doorslaer, H. Z. Hausen, and E.-M. de Villiers, “Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments,” Virology, vol. 401, no. 1, pp. 70–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Chen, M. Terai, L. Fu, R. Herrero, R. DeSalle, and R. D. Burk, “Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses,” Journal of Virology, vol. 79, no. 11, pp. 7014–7023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. I. E. Calleja-Macias, M. Kalantari, J. Huh et al., “Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants,” Virology, vol. 319, no. 2, pp. 315–323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Ho, S.-Y. Chan, R. D. Burk et al., “The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations,” Journal of Virology, vol. 67, no. 11, pp. 6413–6423, 1993. View at Google Scholar · View at Scopus
  32. L. Sichero, S. Ferreira, H. Trottier et al., “High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18,” International Journal of Cancer, vol. 120, no. 8, pp. 1763–1768, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Hildesheim and S. S. Wang, “Host and viral genetics and risk of cervical cancer: a review,” Virus Research, vol. 89, no. 2, pp. 229–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. D'Abramo and J. Archambault, “Small molecule inhibitors of human papillomavirus protein-protein interactions,” The Open Virology Journal, vol. 5, pp. 80–95, 2011. View at Publisher · View at Google Scholar
  35. A. Storey, A. Piccini, P. Massimi, V. Bouvard, and L. Banks, “Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein,” Journal of General Virology, vol. 76, no. 4, pp. 819–826, 1995. View at Google Scholar · View at Scopus
  36. E. Soeda, M. C. Ferran, C. C. Baker, and A. A. McBride, “Repression of HPV16 early region transcription by the E2 protein,” Virology, vol. 351, no. 1, pp. 29–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Lewis, K. Webster, A.-M. Sanchez-Perez, and K. Gaston, “Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein,” Journal of General Virology, vol. 80, no. 8, pp. 2087–2096, 1999. View at Google Scholar · View at Scopus
  38. J. J. Dowhanick, A. A. McBride, and P. M. Howley, “Suppression of cellular proliferation by the papillomavirus E2 protein,” Journal of Virology, vol. 69, no. 12, pp. 7791–7799, 1995. View at Google Scholar · View at Scopus
  39. N. A. Hamid, C. Brown, and K. Gaston, “The regulation of cell proliferation by the papillomavirus early proteins,” Cellular and Molecular Life Sciences, vol. 66, no. 10, pp. 1700–1717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. K. J. Watts, C. H. Thompson, Y. E. Cossart, and B. R. Rose, “Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia,” Journal of Clinical Microbiology, vol. 39, no. 5, pp. 2009–2014, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Pientong, P. Wongwarissara, T. Ekalaksananan et al., “Association of human papillomavirus type 16 long control region mutation and cervical cancer,” Virology Journal, vol. 10, article 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. X.-P. Dong, F. Stubenrauch, E. Beyer-Finkler, and H. Pfister, “Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers,” International Journal of Cancer, vol. 58, no. 6, pp. 803–808, 1994. View at Publisher · View at Google Scholar · View at Scopus